Global investment firm TPG has entered into a binding agreement to acquire a 35% stake in SCHOTT Poonawalla Pvt Ltd, a ...

TPG acquires 35% stake in SCHOTT Poonawalla from Serum Institute of India; SCHOTT Pharma retains 50% while SII continues as ...

TPG, a global alternative asset management firm, has entered into a binding agreement to acquire a 35% stake in SCHOTT ...

Global alternative asset firm TPG has acquired a 35% stake in SCHOTT Poonawalla, a joint venture between SCHOTT Pharma and ...

TPG will acquire a 35% stake in SCHOTT Poonawalla from the Serum Institute of India. This joint venture with SCHOTT Pharma is ...

SCHOTT Pharma, a provider of drug containment solutions and delivery systems for injectable drugs, announced that TPG — a ...

TPG is acquiring a 35% stake in SCHOTT Poonawalla, a joint venture of SCHOTT Pharma and Serum Institute of India. The deal is ...

TPG Growth, TPG’s middle market and growth equity platform, is funding the investment, along with Novo Holdings as a ...

Global alternative asset management firm TPG has entered into a binding agreement to acquire a 35% stake in Schott Poonawalla ...

TPG has entered into a binding agreement to acquire 35% stake in Schott Poonawalla from Serum Institute of India (SII), said ...

The transaction, funded through TPG Growth and co-investor Novo Holdings, is expected to close in the first half of 2025.

Global alternative asset management firm TPG has agreed to acquire a 35% stake in SCHOTT Poonawalla from Serum Institute of India (SII), according to an announcement on Tuesday. S ...